Inventor · disambiguated record
Elizabeth A. Mcfaddin
Also filed as: MCFADDIN ELIZABETH · MCFADDIN ELIZABETH A · MCFADDIN ELIZABETH ANN
20 granted patents·4 pending applications·90 citations·filing 2017–2024
93Inventor score
Top patents by PatentIndex Score
24 records- 0198US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0297US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 0397US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 0496US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 0594US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 0692US10584124B2Crystalline formsARRAY BIOPHARMA INC·Filed 2018·Granted Mar 10, 2020·12 cites·9 claims
- 0791US10172845B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·4 cites·29 claims
- 0889US10144734B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 4, 2018·6 cites·30 claims
- 0988US10441581B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Oct 15, 2019·2 cites·29 claims
- 1087US11998545B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Granted Jun 4, 2024·0 cites·14 claims
- 1184US11697647B2RET kinase inhibitorsLILLY CO ELI·Filed 2021·Granted Jul 11, 2023·1 cites·25 claims
- 1282US10881652B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 5, 2021·2 cites·14 claims
- 1380US2023090520A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1476US2021186959A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1573US11964968B2Compounds useful for inhibiting RET kinaseLILLY CO ELI·Filed 2023·Granted Apr 23, 2024·0 cites·23 claims
- 1672US11648243B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted May 16, 2023·0 cites·20 claims
- 1768US11970485B2RET kinase inhibitorsLILLY CO ELI·Filed 2022·Granted Apr 30, 2024·0 cites·24 claims
- 1865US11613533B2Compounds useful for inhibiting RET kinaseLILLY CO ELI·Filed 2021·Granted Mar 28, 2023·0 cites·25 claims
- 1964US2025197413A1Rxfp1 receptor agonistsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2050US11603374B2Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Mar 14, 2023·0 cites·12 claims
- 2150US2023322682A1Processes and intermediates for the preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 2249US11472802B2Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Oct 18, 2022·0 cites·11 claims
- 2347US11964988B2Fused heterocyclic compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Apr 23, 2024·0 cites·18 claims
- 2440US11655225B2Antimycobacterial heterocyclic amidesCRESTONE INC·Filed 2019·Granted May 23, 2023·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Elizabeth A. Mcfaddin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →